SCHEMBL7657273

SCHEMBL7657273

O=C(O)CCCOc1cccc(NC(=O)Cc2ccc3nc(Nc4cccnc4)oc3c2)c1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 6/20 0.49
P2RY14 Q15391 2/20 0.43
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ESR1 P03372 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
ITGA4 P13612 1/20 0.40
NOTUM Q6P988 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6598330 0.92 P2RY14 (0.49) EPHX2P2RY14USP2HDAC6ITGA4
SCHEMBL7668355 0.85 HDAC6 (0.42) EPHX2KDM4EALDH1A1HDAC6KMT2A
SCHEMBL6594493 0.85 HDAC6 (0.52) EPHX2P2RY14HDAC6MEN1KMT2A
SCHEMBL6595168 0.84 P2RY14 (0.49) P2RY14USP2ALDH1A1HDAC6MEN1
SCHEMBL3866405 0.84 RAB9A (0.45) P2RY14ALDH1A1HDAC6ITGA4
SCHEMBL7430484 0.82 EPHX2 (0.47) EPHX2KDM4EALDH1A1POLBMEN1
SCHEMBL6597368 0.81 NPC1 (0.47) KDM4EUSP2ALDH1A1POLBHPGD
SCHEMBL7659834 0.80 KDM4E (0.52) KDM4EUSP2ALDH1A1ESR1POLB
SCHEMBL7668364 0.80 HDAC6 (0.38) EPHX2ALDH1A1HDAC6ITGA4TSHR
SCHEMBL6165048 0.78 ALDH1A1 (0.41) KDM4EUSP2ALDH1A1ESR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1144393-A3 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR AstraZeneca AB (SE) 2002-09-11 EP disclosed
US-6441012-B1 BENZOXAZOLE OR BENZTHIAZOLE DERIVATIVES FOR INHIBITING THE INTERACTION BETWEEN CELLULAR ADHESION MOLECULES AND/OR FIBRONECTIN AND THE INTERGRIN RECEPTOR ASTRAZENECA AB (SE) 2002-08-27 US disclosed
EP-1144393-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR AstraZeneca AB (SE) 2001-10-17 EP disclosed
WO-2000005224-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR ASTRAZENECA AB (SE) 2000-02-03 WO disclosed